Highlights
lung cancer
LUNG CANCER

Our model including six epidemiological components was successfully validated on both internal and external validation.Risk stratification by the model showed significantly different survival patterns even after discharge.Three well-developed interfaces are friendly to both physicians and patients for prognosis-related conversations.
Our model with easily accessible variables showed its robustness in inferring its predictive value with respect to in-hospital mortality of lung cancer patients.The model is highly applicable in follow-up.Its applications are useful to clinical in the assistance of strategic planning and the improvement of end-of-life care.